Erratum: Role of glutathione transferases in the mechanism of brostallicin activation (Biochemistry (2010) 49 (226) DOI: 10.1021/bi901689s));Role of glutathione transferases in the mechanism of brostallicin activation

Biochemistry

Volumn 49, Issue 1, 2010, Pages 226-235

  Pezzola, Silvia ^a   Antonini, Giovanni ^b   Geroni, Cristina ^c   Beria, Italo ^c   Colombo, Maristella ^c   Broggini, Massimo ^d   Mongelli, Nicola ^c   Leboffe, Loris ^b   MacArthur, Robert ^e   Mozzi, Alessia Francesca ^f   Federici, Giorgio ^g   Caccuri, Anna Maria ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b ROMA TRE UNIVERSITY   (Italy)

^c NERVIANO MEDICAL SCIENCES   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e Cell Therapeutics Inc   (United States)

^f Tor Vergata Foundation Hospital   (Italy)

^g Children's Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADDITION REACTIONS; CELL CULTURE; CYTOTOXICITY; ISOENZYMES; TUMORS;

ANTICANCER ACTIVITIES; CLINICAL EVALUATION; CYTOTOXIC ACTIVITIES; FLUOROMETRIC ASSAY; GLUTATHIONE TRANSFERASE; MICHAEL ADDITION REACTIONS; REACTIVE SPECIES; SEQUENCE-SPECIFIC MANNER;

PEPTIDES;

BROSTALLICIN; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE M2; GLUTATHIONE TRANSFERASE P1; ISOENZYME;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CATALYSIS; CELL STRAIN MCF 7; CHEMICAL STRUCTURE; CYTOTOXICITY; DRUG ACTIVATION; DRUG EFFICACY; DRUG PROTEIN BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MICHAEL ADDITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEADY STATE; TUMOR CELL;

EID: 73449133782     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi100755e     Document Type: Erratum

References (32)

1. Romagnoli, R., Baraldi, P. G., Cruz-Lopez, O., Lopez-Cara, C., and Preti, D. (2009) α-Halogenoacrylic derivatives of antitumor agents. Mini Rev. Med. Chem. 9, 81-94.
2. Pook, S. H., Toh, C. K., and Mahendran, R. (2006) Combination of thiol antioxidant Silibinin with Brostallicin is associated with increase in the anti-apoptotic protein Bcl-2 and decrease in caspase 3 activity. Cancer Lett. 238, 146-152.
3. Sabatino, M. A., Colombo, T., Geroni, C., Marchini, S., and Broggini, M. (2003) Enhancement of in vivo antitumor activity of classical anticancer agents by combination with the new, glutathione-interacting DNA minor groove-binder, brostallicin. Clin. Cancer Res. 9, 5402-5408.
4. Geroni, C., Marchini, S., Cozzi, P., Galliera, E., Ragg, E., Colombo, T., Battaglia, R., Howard, M., D'Incalci, M., and Broggini, M. (2002) Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione. Cancer Res. 62, 2332-2336.
5. Cozzi, P. (2001) A new class of cytotoxic DNA minor groove binders: R-halogenoacrylic derivatives of pyrrolecarbamoyl oligomers. Farmaco 56, 57-65.
6. Fedier, A., Fowst, C., Tursi, J., Geroni, C., Haller, U., and Marchini, S. (2003) Brostallicin (PNU-166196) a newDNAminor groove binder that retains sensitivity in DNA mismatch repair-deficient tumour cells. Br. J. Cancer 89, 1559-1565.
7. Guirouilh-Barbat, J., Zhang, Y.-W., and Pommier, Y. (2009) Induction of glutathione-dependent DNA double-strand breaks by the novel anticancer drug brostallicin. Mol. Cancer Ther. 8, 1985-1994.
8. Beria, I., Baraldi, P. G., Cozzi, P., Caldarelli, M., Geroni, C., Marchini, S., Mongelli, N., and Romagnoli, R. (2004) Cytotoxic α-halogenoacrylic derivatives of distamycin A and congeners. J. Med. Chem. 47, 2611-2623.
9. Cozzi, P. (2003) The discovery of a new potential anticancer drug: A case history. Farmaco 58, 213-220.
10. Broggini, M., Marchini, S., Fontana, E., Moneta, D., Fowst, C., and Geroni, C. (2004) Brostallicin: A new concept in minor groove DNA binder development. Anticancer Drugs 15, 1-6.
11. Townsend, D. M., and Tew, K. D. (2003) The role of glutathione- Stransferase in anti-cancer drug resistance. Oncogene 22, 7369-7375.
12. Tew, K. D., Monks, A., Barone, L., Rosser, D., Akerman, G., Montali, J. A., Wheatley, J. B., and Schmidt, D. E., Jr. (1996) Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program. Mol. Pharmacol. 50, 149-159.
13. Moscow, J. A., Townsend, A. J., and Cowan, K. H. (1989) Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins. Mol. Pharmacol. 36, 22-28.
14. Townsend, A. J., Chen-Pei, D. Tu., and Cowan, K. H. (1992) Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: Effect on cellular sensitivity to cytotoxic agents. Mol. Pharmacol. 41, 230-236.
15. Lo Bello, M., Battistoni, A., Mazzetti, A. P., Board, P. G., Muramatsu, M., Federici, G., and Ricci,G. (1995) Site-directed mutagenesis of human glutathione transferase P1-1. Spectral, kinetic, and structural properties of Cys-47 and Lys-54 mutants. J. Biol. Chem. 270, 1249-1253.
16. Habig,W. H., and Jakoby, W. B. (1981) Assays for differentiation of glutathione S-transferases. Methods Enzymol. 77, 398-405.
17. Gill, S. C., and von Hippel, P. H. (1989) Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182, 319-326.
18. Segel, H. I. (1993) Enzyme Kinetic Behavior and Analysis of Rapid Equilibrium and Stady-State Enzyme System , JohnWiley&Sons, Inc., New York.
19. Hoops, S., Sahle, S., Gauges, R., Lee, C., Pahle, J., Simus, N., Singhal, M., Xu, L., Mendes, P., and Kummer, U. (2006) COPASI: A COmplex PAthway SImulator. Bioinformatics 22, 3067-3074.
20. Ponti, M., Forrow, S. M., Souhami, R. L., D'Incalci, M., and Hartley, J. A. (1991) Measurement of the sequence specificity of covalentDNA modification by antineoplastic agents using Taq DNA polymerase. Nucleic Acids Res. 19, 2929-2933.
21. Marchini, S., Cozzi, P., Beria, I., Geroni, C., Capolongo, L., D'Incalci, M., and Broggini, M. (1998) Sequence-specific DNA alkylation of novel tallimustine derivatives. Anti-Cancer Drug Des. 13, 193-205.
22. Bredereck, H., Gompper, R., and Theilig, G. (1954) Formamide reactions. III. Reactions of halogen compounds with formamide. Chem. Ber. 87, 537-546.
23. Guest, H. H. (1947) Isomeric chlorinated long-chain esters. J. Am. Chem. Soc. 69, 300-302.
24. Nam, J., Lee, S., Kim, K., Yong, P., and Yong, S. (2002) Asymmetric syntheses of R-mercapto carboxylic acid derivatives by dynamic resolution of N-methyl pseudoephedrine R-bromo esters. Tetrahedron Lett. 43, 8253-8255.
25. van Iersel, M. L., Ploemen, J. P., Lo Bello, M., Federici, G., and van Bladeren, P. J. (1997) Interactions of α,β-unsaturated aldehydes and ketones with human glutathione S-transferase P1-1. Chem.-Biol. Interact. 108, 67-78.
26. Caccuri, A. M., Antonini, G., Board, P. G., Parker, M. W., Nicotra, M., Lo Bello, M., Turella, P., Federici, G., and Ricci, G. (1999) Proton release on binding of glutathione to alpha, mu and delta class glutathione transferases. Biochem. J. 344, 419-425.
27. D'Incalci, M., and Sessa, C. (1997) DNA minor groove binding ligands: A new class of anticancer agents. Expert Opin. Invest. Drugs 6, 875-884.
28. Chartier, H. (1972) Action of sulfenyl chlorides on crotonic derivatives. Bull. Soc. Chim. Fr. 7, 2887-2895.
29. Oakley, A. J., Rossjohn, J., Lo Bello, M., Caccuri, A. M., Federici, G., and Parker, M. W. (1997) The three-dimensional structure of the human pi class glutathione transferase P1-1 in complex with the inhibitor ethacrynic acid and its glutathione conjugate. Biochemistry 36, 576-585.
30. Raghunathan, S., Chandross, R. J., Kretsinger, R. H., Allison, T. J., Penington, C. J., and Rule, G. S. (1994) Crystal structure of human class mu glutathione transferase GSTM2-2. Effects of lattice packing on conformational heterogeneity. J. Mol. Biol. 238, 815-832.
31. Hamilton, D. S., Zhang, X., Ding, Z., Hubatsch, I., Mannervik, B., Houk, K. N., Ganem, B., and Creighton, D. J. (2003) Mechanism of the Glutathione Transferase-Catalyzed Conversion of Antitumor 2-Crotonyloxymethyl-2- cycloalkenones toGSHAdducts. J. Am. Chem. Soc. 125, 15049-15058.
32. Townsend, D. M., Findlay, V. L., and Tew, K. D. (2005) Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets. Methods Enzymol. 401, 287-307.